Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2022.Jul.21

Announcement on behalf of subsidiary, Obigen Pharma Inc., that BOD resolved the Term Sheet for licensing of OBI-858 in China

2022.Jul.04

SUPPLEMENTARY STATEMENTS ON NEWS ARTICLE

2022.Jul.01

The Company announces discontinuation of the Phase II Study of OBI-888

2022.Jun.27

Announcement of the status of implementation of the commitments during the up-listing at Taipei Exchange

2022.Jun.27

The Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board

2022.Jun.27

Announcement of 2022 shareholders' meeting resolution to lift the non-competition restrictions for new directors

2022.Jun.27

Announcement of 5th Remuneration Committee Members

2022.Jun.27

Announcement of 4th Audit Committee Members

2022.Jun.27

Announcement of Re-election of directors at the 2022 annual shareholders’ meeting

2022.Jun.27

Announcement of the Company’s important resolutions of the 2022 annual shareholders’ meeting

News

Latest News

Events

Latest events